The Week in Review: Shaanxi Bicon Pharma Raises $250 Million
Shaanxi Bicon Pharma raised $250 million from private equity fund PAG Asia Capital; MBK Partners, a PE group based in Korea, sold its 77% interest in Luye Pharma Group to three other PE firms; C3 Jian, a dental spinoff from UCLA with a China subsidiary, announced a new $30 million funding round; Shijiazhuang Yiling Pharma revealed plans to invest $22 million into innovative collaborations with other China pharmas; Tibet Pharma will go private at $3 per share; Cumberland Pharma of the US out-licensed the China rights for two of its drugs to Harbin Gloria Pharma; and Shanghai Pharma will collaborate with Guangdong Province’s CDC on cold chain drug distribution. More details…. Stock Symbols: (SHE: 002603) (NSDQ: TBET) (NSDQ: CPIX) (SHE: 002437) (SHA: 601607; HK: 02607) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here